Home > Healthcare > Medical Devices > Therapeutic Devices > In-vitro Fertilization (IVF) Market

In-vitro Fertilization (IVF) Market Trends

Report ID: GMI11083
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

In-vitro Fertilization Market Trends

The increasing number of infertility cases is a significant driver of the market.
For instance, according to the WHO, 1 in 6 people globally suffers from infertility, indicating a high need for appropriate fertility care.
Technological advancements have significantly improved IVF success rates. For example, the success rate of IVF has increased from around 10% in the 1980s to approximately 30-35% per cycle in 2023, depending on the age of the woman.
Time-lapse imaging technology allows embryologists to monitor embryo development more closely, improving selection and implantation success rates. This technology has contributed to the overall increase in IVF success rates.
Additionally, IVF is becoming more culturally accepted in many parts of the world. For instance, countries in the Middle East and Asia, where assisted reproductive technology was once stigmatized, are now seeing significant growth in IVF usage.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The in-vitro fertilization industry was valued at USD 20.2 billion in 2023 and is set to register 5.7% CAGR from 2024 to 2032 primarily driven by increasing infertility rates across the world

The conventional procedure segment in the market is expected to witness 5.4% CAGR from 2024 to 2032 as it has higher success rates compared to other forms of IVF, such as natural cycle IVF or mini-IVF.

North America IVF market is anticipated to reach USD 9.8 billion by 2032 led by latest advancements in reproductive medicine

Cook Medical, Esco Medical, FUJIFILM Irvine Scientific, Inc., GE HealthCare Technologies, Inc., Genea BIOMEDX, Gynemed GmBH & Co. KG, Hamilton Thorne Ltd., IVFtech ApS, and Kitazato Corporation, among others